4DMedical valuation
$2.16Change from previous close: −4.42%Absolute change: −$0.10
Valuation
The average price target of 3 analysts is $4.17.
Data as of November 22, 2026
4DMedical compared with similar companies
4DMedical's Price/book: 7.58, +31% against the median of a group of 7 similar companies (5.80).
| Metric | 4DMedical | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/book | 7.58 | 5.80 | 4.13 – 13.9 | Middle |
| Price/sales | 184.2 | 12.5 | 7.14 – 54.8 | High |
| Gross margin | 93.8% | 75.0% | 58.0% – 90.3% | High |
| Operating margin | -813.7% | 19.5% | -71.5% – 28.5% | Low |
| Net margin | 0.0% | 12.8% | -6.3% – 25.2% | Middle |
| ROE | -174.4% | 11.8% | -19.8% – 14.1% | Low |
| Debt/equity | 1.06 | 0.08 | 0.02 – 0.70 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $1.3B
- Enterprise value
- $1.2B
- P/E (trailing 12 months)
- -11.4
- Forward P/E
- -81.5
- EV/EBITDA
- -21.5
- EV/revenue
- 170.2
Profitability and growth
- ROA
- -15.6%
- ROIC
- -17.1%
- Revenue growth (year over year)
- 42.3%
- Earnings growth (year over year)
- 124.6%
Financial health
- Total cash
- $277.95M
- Total debt
- $180.24M
- Current ratio
- 30.8
- Quick ratio
- 30.5
- Altman Z-Score
- 3.79
- Piotroski F-Score
- 3.00
Dividends
- Dividend yield
- 0.0%
Analysts and estimates
- Average price target
- $4.17
- Median price target
- $4.10
- High price target
- $6.00
- Low price target
- $2.40
- Analysts with a price target
- 3
- Forward EPS
- -$0.03
- EPS estimate, current year
- -$0.06
Shares and trading
- Beta
- 1.94
- Average volume
- 4.49M
- Shares outstanding
- 602.34M
- Float
- 498.38M
- Institutional ownership
- 25.3%
- Insider ownership
- 16.6%
